10 Most Profitable Healthcare Stocks to Buy
By far, the healthcare sector remains among the most resilient and profitable in global equity markets.
Vertex Pharmaceuticals Inc / Ma (VRTX)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Impax Asset Management Ian Simm | 4,622 | $2,095,430 | 0.01% | |
| 2. | Bourgeon Capital John Zaro | 483 | $218,973 | 0.04% | |
| 3. | Sivik Global Healthcare Krishen Sud | 13,770 | $6,243 | -2% | 1.81% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $389.95 | 5,710 | $2,226,614.50 | 115,968 | 2025-08-06 | Filing | |
| $389.08 | 4,290 | $1,669,153.20 | 110,258 | 2025-08-06 | Filing | |
| $389.84 | 3,366 | $1,312,201.44 | 45,000 | 2025-08-06 | Filing | |
| $389.36 | 1,634 | $636,214.24 | 41,634 | 2025-08-06 | Filing | |
| $196.34 | 4,243 | $833,070.62 | 73,754 | 2021-08-19 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $474.99 | 4,500 | $2,137,455.00 | 42,293 | 2026-01-07 | Filing | |
| $461.00 | 9,532 | $4,394,252.00 | 37,725 | 2026-01-06 | Filing | |
| $461.00 | 7,000 | $3,227,000.00 | 37,725 | 2025-12-03 | Filing | |
| $451.00 | 7,000 | $3,157,000.00 | 44,725 | 2025-12-03 | Filing | |
| $449.99 | 4,500 | $2,024,955.00 | 46,793 | 2025-12-03 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 24,105,823 | $10,928,615,915 | 0.16% | |
| 2. | 3,249,541 | $1,473,211,801 | 0.88% | |
| 3. | 832,853 | $377,582,236 | 0.52% | |
| 4. | 752,425 | $342,202,401 | 0.33% | |
| 5. | 654,470 | $296,710,519 | 0.17% |
News See All
Here’s Why Hardman Johnston Global Equity Strategy Sold Vertex Pharmaceuticals (VRTX)
Hardman Johnston Global Advisors, an investment management company, released its “Hardman Johnston Global Equity Strategy” investor letter for the fourth quarter of 2025. A copy of the letter can...
Bernstein Names Vertex (VRTX) a "Top Biotech Pick" for 2026 Following Upgrade to Outperform
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) is one of the best future stocks to buy for the long term.
12 Best Future Stocks to Buy For the Long Term
On January 6, Dan Ives of Wedbush Securities joined 'Closing Bell' on CNBC to suggest that the tech bull market continues to play out.
Here’s What Lifted Vertex Pharmaceuticals (VRTX) in Q4
ClearBridge Investments, an investment management company, released its “ClearBridge Growth Strategy” fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Should You Be Confident in Vertex Pharmaceuticals Incorporated’s (VRTX) Long-Term Outlook?
Hardman Johnston Global Advisors, an investment management company, released its “Hardman Johnston Global Equity Strategy” investor letter for the third quarter of 2025. A copy of the letter can ...
Harding Loevner Global Equity’s Views on Vertex Pharmaceuticals Incorporated (VRTX)
Harding Loevner, an asset management company, released its “Global Equity Strategy” third-quarter 2025 investor letter. A copy of the letter can be downloaded here.
What Do Analysts Think About Vertex Pharmaceuticals (VRTX)?
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) is one of the best large cap stocks to invest in for the long term.
13 Best Large Cap Stocks to Invest in For the Long Term
Pies does not see anything fundamentally broken in today’s markets and stated that if we go through our checklist, we can see that a recession does not seem imminent.
Stifel Maintains Hold Rating on Vertex (VRTX), Keeps $445 Price Target
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) is one of the best gene-editing stocks to buy according to hedge funds.
Hedge Fund Resource Center Billionaire Hedge Funds
